# Fecal ESBL Resurgence During Antibiotic Treatment

> **NCT03206879** · — · TERMINATED · sponsor: **University Hospital, Akershus** · enrollment: 50 (actual)

## Conditions studied

- Antibiotic Drug Resistance

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03206879
- **Lead sponsor:** University Hospital, Akershus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-11
- **Primary completion:** 2018-08
- **Final completion:** 2018-12
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Several sites did not manage to recruit patients.
- **Last updated:** 2024-02-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03206879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03206879, "Fecal ESBL Resurgence During Antibiotic Treatment". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03206879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*